Morgan Joseph initiates coverage on Spectrum Pharmaceuticals (Nasdaq: SPPI) with a Buy. Price target $5.

Morgan analyst says ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE